Concepedia

Sarah Barrin

SB

Statistics

Publications

9

Citations

1.5K

H-Index

9

Active since

2017

Affiliations

Inserm(Current)

Centre National de la Recherche Scientifique

Institut Cochin

Université Paris Cité

Centre de Recherche des Cordeliers

Sarah Barrin is an author at Inserm specializing in oncology, immunology, and cancer immunotherapy.

ORCID

Publications per year

2017–2025

9

Publications

9

Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment

Elisa Peranzoni, Jean Lemoine, Lene Vimeux et al. · Proceedings of the National Academy of Sciences · 2018 · 934 citations · Full text

, , +17

Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment

Alba Nicolás‐Boluda, Javier Vaquero, Lene Vimeux et al. · eLife · 2021 · 346 citations · Full text

, , +17

CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1

Chahrazade Kantari‐Mimoun, Sarah Barrin, Lene Vimeux et al. · Cancer Immunology Research · 2021 · 70 citations · Full text

, , +15

CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1.

Chahrazade Kantari‐Mimoun, Sarah Barrin, Lene Vimeux et al. · PubMed · 2021 · 47 citations

, , +15

The Spatial Organization of cDC1 with CD8+ T Cells is Critical for the Response to Immune Checkpoint Inhibitors in Patients with Melanoma

Élisa Gobbini, Margaux Hubert, Anne‐Claire Doffin et al. · Cancer Immunology Research · 2025 · 23 citations

, , +17

1–5 of 9